UC blood-derived mesenchymal stromal cells: an overview.
The UC is a readily available source of blood that may be used for analysis and treatment. Some authors suggest that within the UC blood (UCB) are cells with potential for differentiation down mesenchymal lineages. Isolation and characterization of these cells has been accomplished in some centers. Differentiation of these cells down multiple lineages has been documented. Surface marker expression and gene expression profiling has been performed, and mesenchymal stromal cells (MSC) from BM and adipose tissue have been compared with those derived from UCB. The use of UCB-derived stem cells has been investigated in pre-clinical studies. As this field is rapidly advancing, this review summarizes the current state of our knowledge of MSC derived from UCB.
Flynn
A
A
Regenerative Medicine Institute (REMEDI), National Centre for Biomedical Engineering Science (NCBES), National University of Ireland (NUI), Galway, Ireland.
Barry
F
F
O'Brien
T
T
D000818:Animals; D015703:Antigens, CD / Q000276:immunology; D018952:Antigens, CD34 / Q000276:immunology; D002318:Cardiovascular Diseases / Q000628:therapy; D002454:Cell Differentiation; D019070:Cell Lineage; D002469:Cell Separation; D036101:Cord Blood Stem Cell Transplantation / Q000379:methods / Q000639:trends; D016207:Cytokines / Q000276:immunology / Q000378:metabolism; D005260:Female; D005312:Fetal Blood / Q000166:cytology*; D006801:Humans; D016130:Immunophenotyping; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000502:physiology; D051379:Mice; D009422:Nervous System Diseases / Q000628:therapy; D011247:Pregnancy; D051381:Rats
D015703:Antigens, CD; D018952:Antigens, CD34; D016207:Cytokines